Full Cycle Bioplastics
PrivateLast Round
Bankruptcy
Jun 21, 2023
Total Funding Raised
$2.2M
Company Overview
Full Cycle Bioplastics is a clean technology company that develops a proprietary process to convert organic waste into polyhydroxyalkanoate (PHA), a compostable and marine-degradable bioplastic alternative to petroleum-based plastics.
Sector
Energy & Sustainability
Verticals
Sustainable Materials, Biotechnology, Circular Economy, Waste Management
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Full Cycle Bioplastics Comparables
Compare Full Cycle Bioplastics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genecis Bioindustries | 88% | |
| TerraVerdae Bioworks | 86% | |
| Mango Materials | 83% | |
Full Cycle Bioplastics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Bankruptcy | Jun 21, 2023 | ||||
| Series A | Feb 17, 2022 | ||||
| Grant | Jan 29, 2018 | ||||
| Seed | Apr 30, 2014 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2022
Completed a Series A funding round.
Full Cycle Bioplastics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Full Cycle Bioplastics's valuation, stock price, and market status.